ClinicalTrials.gg
CompletedNCT00869609Updated Jun 24, 2016Results posted

Evaluation of Group Lifestyle Balance Maintenance Strategies

An interventional study of GLB Traditional Maintenance (TM) and GLB-Carb-focused Maintenance (CF) in Diabetes, sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-06-24.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Heart disease is a leading cause of death in people in the United States. It is a major problem for those with diabetes. Conditions called the metabolic syndrome and pre-diabetes increase risk for diabetes and heart disease. The metabolic syndrome is a group of disorders that occur at the same time. Overall, one in four American adults has the metabolic syndrome. It is more common in people over the age of 40. The metabolic syndrome includes: 1) large waist size, 2) high triglycerides, 3) low HDL cholesterol, 4) high blood pressure and 5) high fasting blood sugar. People with the metabolic syndrome have at least three of these five risk factors. Pre-diabetes is considered to be present in those with high fasting blood sugar levels below the diabetes range.

Research has shown that type 2 diabetes and the metabolic syndrome may be prevented or delayed by making lifestyle changes. It is not known what will most help people continue these healthy changes over time. The purpose of this study is to look at ways to help people continue the healthy lifestyle changes they have made while taking part in a diabetes prevention program called Group Lifestyle Balance (GLB).

Read the detailed description

Objective: To determine the effectiveness of the Group Lifestyle Balance (GLB) program with an added maintenance component focusing on carbohydrate reduction and hunger management when compared to the GLB program with traditional maintenance.

Research Design and Methods: The original Diabetes Prevention Program intervention was modified from a 16 session individual intervention to a 12 session group-based program called Group Lifestyle Balance (GLB). The Diabetes Prevention Support Center (DPSC) has been created to oversee the implementation of diabetes prevention and CVD risk reduction in various community settings. GLB is a 12-session group based program that focuses on a low fat diet, weight loss and physical activity. This evidence-based intervention is directed at those with pre-diabetes and/or the metabolic syndrome. A monthly maintenance component will be added which provides support in assisting individuals who have completed the 12-session course in the maintenance of healthy lifestyle changes.

The efficacy (in terms of weight reduction) of an added maintenance component focusing on carbohydrate reduction and hunger management will be compared to traditional maintenance. Participants will be randomly assigned to either GLB traditional maintenance (GLB-TM) or GLB and carbohydrate reduced maintenance (GLB-CRM). There will be two groups of approximately 15 subjects in each intervention assignment, for a total of approximately 30 subjects per intervention group and approximately 60 subjects taking part overall. Efficacy in both groups will be assessed by pre and post-intervention measures of diet (weight loss) and physical activity (the keystones of the intervention), as well as the achievement of the two goals: a 7% weight loss by the end of 6 months and 150 minutes of physical activity per week. Secondary outcomes to be evaluated include the reduction of global CVD risk, as assessed by the Framingham Score, the presence of metabolic syndrome (NCEP ATP III), and a fall in blood sugar. Repeat measures will be obtained at six months and one year for further evaluation and comparison.

02

Conditions studied

  • Diabetes

Browse trials for

Keywords

  • Diabetes Prevention
  • CVD Risk Reduction
  • Lifestyle Intervention
03

In context

Diabetes Mellitus

11,089 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 60 is below the median of 80 across 8,491 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,414 studies on the registry; 168 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Non-diabetic patients with metabolic syndrome AND/OR pre-diabetes are eligible for this project based on the following criteria:

  1. Metabolic Syndrome:

    Patients with BMI ≥ 25 kg/m2, with at least 3 of the following risk factors for metabolic syndrome:

    • Waist circumference (>40 inches men, >35 inches women)
    • Blood pressure ≥130 mmHg (systolic) or ≥85 mmHg (diastolic) OR history of diagnosed hypertension
    • Low HDL level (\<40mg/dL men, \<50 mg/dL women)
    • Elevated triglyceride level ≥150 mg/dL
    • Fasting glucose ≥100mg/dL and \<126mg/dL
  2. Pre-diabetes:

Patients with a BMI ≥25 kg/m2 and pre-diabetes (fasting glucose ≥100 mg/dL and \<126mg/dL)

All measures should have been taken within one year of enrollment into the study. A permission for physical activity form must be signed by the participant's physician in order to take part in the study.

Exclusion criteria

Exclusion Criteria:

  • Previous diabetes or diabetes diagnosed as a result of the screening
  • Age \<18 years old
  • Women who are currently (or within past 6-weeks) pregnant or lactating
  • Any patient deemed by their physician not to be a candidate
  • Any patient planning to leave the area before the end of the GILS
  • Any patient who is unable to provide informed consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    GLB Traditional Maintenance (TM)

    Group Lifestyle Balance (GLB) program Traditional Maintenance: After completion of the GLB 12 core sessions, participants who are randomly assigned to GLB program Traditional Maintenance (TM) will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions.

    Behavioral: GLB Traditional Maintenance (TM)

  • Active comparator
    GLB-Carb-focused Maintenance (CF)

    Group Lifestyle Balance (GLB) program Carb-focused Maintenance: After completion of the GLB 12 core sessions, participants randomly assigned to GLB Carb-focused Maintenance (CF) will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information regarding healthy carbohydrate intake and hunger management.

    Behavioral: GLB-Carb-focused Maintenance (CF)

Interventions

  • BehavioralGLB Traditional Maintenance (TM)

    After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. Participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management.

  • BehavioralGLB-Carb-focused Maintenance (CF)

    After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. GLB-CF participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management.

06

What researchers measure

Primary outcomes

  1. Change in Weight

    Weight was measured twice without shoes with the average computed; participants were asked to remove their shoes at each measure.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

Secondary outcomes

  1. Change in Total Cholesterol

    Total cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  2. Change in HDL Cholesterol

    High-density lipoprotein (HDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  3. Change in LDL Cholesterol

    Low-density lipoprotein (LDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  4. Change in Triglycerides

    Triglycerides were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  5. Change in Fasting Glucose

    Fasting plasma glucose was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  6. Change in Glycosylated Hemoglobin A1c (HbA1c)

    Collected via venous blood draw, the HbA1c level reflects glucose concentration over the previous period (approximately 8-12 weeks, depending on the individual) and provides an indication of long-term glycemic control.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  7. Change in Systolic Blood Pressure

    Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  8. Change in Diastolic Blood Pressure

    Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

  9. Change in Waist Circumference

    Waist circumference was measured at the midpoint between the lower rib margin and the iliac crest; the measurement was repeated twice and the average computed.

    Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group

07

Results

Posted Feb 9, 2016
Limitations and caveats
The sample size was small and included primarily white individuals, so these results may not be generalizable to other groups. The CPC was not carbohydrate restricted and may not be directly comparable to studies that focus on carbohydrate reduction.

Participant flow

The project was implemented in two settings: the first within an urban University campus and the second at a suburban YMCA. Recruitment commenced in May 2009 and was completed in July 2009.

Participant flow — Overall Study
MilestoneGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Started3129
Completed2526
Not completed63

Outcome measures

PrimaryChange in Weight

Weight was measured twice without shoes with the average computed; participants were asked to remove their shoes at each measure.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · pounds
Change in Weight
poundsGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in Weight2.1 ± 5.90.2 ± 7.1
SecondaryChange in Total Cholesterol

Total cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · mg/dl
Change in Total Cholesterol
mg/dlGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in Total Cholesterol8.6 ± 23.215.4 ± 23.7
SecondaryChange in HDL Cholesterol

High-density lipoprotein (HDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · mg/dl
Change in HDL Cholesterol
mg/dlGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in HDL Cholesterol2.9 ± 7.05.1 ± 6.4
SecondaryChange in LDL Cholesterol

Low-density lipoprotein (LDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · mg/dl
Change in LDL Cholesterol
mg/dlGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in LDL Cholesterol5.2 ± 20.05.8 ± 23.3
SecondaryChange in Triglycerides

Triglycerides were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · mg/dl
Change in Triglycerides
mg/dlGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in Triglycerides-0.003 ± 0.22-0.006 ± 39
SecondaryChange in Fasting Glucose

Fasting plasma glucose was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · mg/dl
Change in Fasting Glucose
mg/dlGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in Fasting Glucose1.2 ± 4.70.2 ± 6.9
SecondaryChange in Glycosylated Hemoglobin A1c (HbA1c)

Collected via venous blood draw, the HbA1c level reflects glucose concentration over the previous period (approximately 8-12 weeks, depending on the individual) and provides an indication of long-term glycemic control.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · percentage of glycosylated hemoglobin
Change in Glycosylated Hemoglobin A1c (HbA1c)
percentage of glycosylated hemoglobinGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in Glycosylated Hemoglobin A1c (HbA1c)-0.06 ± 0.18-0.08 ± .18
SecondaryChange in Systolic Blood Pressure

Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · mmHg
Change in Systolic Blood Pressure
mmHgGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in Systolic Blood Pressure-0.43 ± 10.5-3.6 ± 10.8
SecondaryChange in Diastolic Blood Pressure

Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · mmHg
Change in Diastolic Blood Pressure
mmHgGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in Diastolic Blood Pressure-2.1 ± 7.0-3.2 ± 8.8
SecondaryChange in Waist Circumference

Waist circumference was measured at the midpoint between the lower rib margin and the iliac crest; the measurement was repeated twice and the average computed.

Time frame:
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Reported as:
Mean · inches
Change in Waist Circumference
inchesGLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)
Change in Waist Circumference-0.4 ± 1.3-0.2 ± 1.4

Adverse events

Collected over Approximately 1 year.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
GLB Traditional Maintenance (TM)—0/31 (0%)0/31 (0%)
GLB-Carb-focused Maintenance (CF)—0/29 (0%)0/29 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)GLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)Total
Mean55.9 ± 9.453.4 ± 11.654.7 ± 10.5
Sex: Female, Male
Sex: Female, Male(Participants)GLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)Total
Female201939
Male111021
Region of Enrollment
Region of Enrollment(participants)GLB Traditional Maintenance (TM)GLB-Carb-focused Maintenance (CF)Total
United States312960
08

Study locations

1 site
  • Diabetes Prevention Support Center
    Pittsburgh, Pennsylvania 15213, United States
09

References and documents

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2009, a primary completion of Aug 2010 and a completion of Aug 2010. It does not say whether these dates are actual or estimated.

Results were first posted in Feb 2016, 5 years 6 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2009
First posted
Mar 26, 2009
Start
Mar 2009
Primary completionActual
Aug 2010
CompletionActual
Aug 2010
Results first posted
Feb 9, 2016
Last update
Jun 24, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00869609
Collaborators
Robert C. Atkins Foundation
Responsible party
Trevor J. Orchard (Professor, University of Pittsburgh) — Principal investigator
First posted
Mar 26, 2009
Start date
Mar 2009
Primary completion
Aug 2010
Completion
Aug 2010
Results posted
Feb 9, 2016
Last update
Jun 24, 2016

Study contacts

Trevor J Orchard, MD
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion